Home > Official notices > Statutory Committee  |  Search

PJ Online homeThe Pharmaceutical Journal
Vol 279 No 7461 p85
21 July 2007


Statutory Committee

The Statutory Committee will meet at the Royal Pharmaceutical Society of Great Britain, 1 Lambeth High Street, London SE1, at 9.30am on Monday 23, Tuesday 24, Wednesday 25 and Thursday 26 July 2007 to hear the following matters:

1. The committee will resume the inquiry into a complaint by the Council of the Society against Ian Anthony McAsey (registration number 85173) which alleges that the authorisation and subsequent receiving of payments of £212 and £336, which he was not entitled to, while working as a locum pharmacist and the subsequent failure to report or repay the amount, may amount to misconduct.

2. The committee will resume the inquiry into a complaint by the Council of the Society against Nathan Burgess Simpson (registration number 1077828) which alleges that the creation of a personal website while a preregistration student in which he used MRPharmS after his name when he was not entitled to, and included directional links to other websites which contained pornographic material and/or other material that others might find offensive, may amount to misconduct.

3. The committee will hear the new inquiry into a complaint by the Council of the Society against Mohammed Shabir (registration number 87816) which alleges that dispensing or causing to be dispensed to members of the public medication which had previously been dispensed to patients in a care home and which had been subsequently returned unused to the pharmacy; instructing a dispenser to use such returned medication from the care home for community patients, telling her that these people would not understand the significance of the numbers written on the packaging; failing to ensure (a) that Controlled Drugs were kept in a locked cabinet, safe or room, (b) the safety and quality of medicines supplied to patients, (c) that returned medicines were not supplied to patients, (d) that pharmaceutical waste was segregated from pharmacy stock, and (e) that batch and expiry details were included on all stocks of medicines and that pharmaceutical waste was promptly transferred to disposal containers, may amount to misconduct.

4. The committee will hear the new inquiry into a complaint by the Council of the Society against Peter Howard Freeman (registration number 86570) and P. H. Freeman Ltd which alleges that signing and submitting to Leeds West Primary Care Trust on or about 15 April 2005 a fitness-to-practise declaration containing information which Mr Freeman knew to be false; signing and submitting to South Leeds PCT on or about 17 April 2005 a fitness-to-practise declaration containing information which Mr Freeman knew to be false; and, failing to disclose in a letter to Leeds West PCT (a) the company’s conviction on 12 January 1999, (b) Mr Freeman’s conviction on 12 January 1999 and (c) Mr Freeman’s conviction on 19 February 2004, may amount to misconduct.

Fitness to Practise Committees Secretariat

Back to Top


©The Pharmaceutical Journal